JP2023533003A5 - - Google Patents
Info
- Publication number
- JP2023533003A5 JP2023533003A5 JP2023500425A JP2023500425A JP2023533003A5 JP 2023533003 A5 JP2023533003 A5 JP 2023533003A5 JP 2023500425 A JP2023500425 A JP 2023500425A JP 2023500425 A JP2023500425 A JP 2023500425A JP 2023533003 A5 JP2023533003 A5 JP 2023533003A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- pharmaceutically acceptable
- isomer
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010633550.2 | 2020-07-06 | ||
| CN202010633550.2A CN113896711A (zh) | 2020-07-06 | 2020-07-06 | 杂环类免疫调节剂 |
| PCT/CN2021/102873 WO2022007659A1 (zh) | 2020-07-06 | 2021-06-28 | 杂环类免疫调节剂 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023533003A JP2023533003A (ja) | 2023-08-01 |
| JP2023533003A5 true JP2023533003A5 (cg-RX-API-DMAC7.html) | 2024-05-14 |
| JP7712703B2 JP7712703B2 (ja) | 2025-07-24 |
Family
ID=79186707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023500425A Active JP7712703B2 (ja) | 2020-07-06 | 2021-06-28 | ヘテロ環式免疫調節物質 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230271933A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4177247A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7712703B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230037035A (cg-RX-API-DMAC7.html) |
| CN (2) | CN113896711A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021303635A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3189041A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023000382A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022007659A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025522795A (ja) * | 2022-06-27 | 2025-07-17 | ピン セラピューティクス、インコーポレイテッド | カゼインキナーゼ1アルファを分解するための化合物及び方法 |
| JP2025531869A (ja) | 2022-09-09 | 2025-09-25 | イノヴォ セラピューティクス、インコーポレイテッド | CK1αおよびDUAL CK1α/GSPT1分解化合物 |
| EP4644382A4 (en) * | 2022-12-27 | 2026-04-01 | Gluetacs Therapeutics Shanghai Co Ltd | ISOINDOLINONE SKELETON-BASED COMPOUND WITH SULFUR/OXYGEN SUBSTITUTED GLUTARIMIDE AND ITS USE |
| WO2024222614A1 (zh) * | 2023-04-28 | 2024-10-31 | 北京诺诚健华医药科技有限公司 | 杂环类gspt1降解剂 |
| WO2025179161A1 (en) | 2024-02-21 | 2025-08-28 | Innovo Therapeutics, Inc. | Protein degrading compounds |
| WO2025195464A1 (zh) * | 2024-03-21 | 2025-09-25 | 上海惠康济民生物医药技术有限公司 | 取代的异吲哚啉类化合物、制备方法、药物组合物及应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG183257A1 (en) * | 2010-02-11 | 2012-09-27 | Celgene Corp | Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same |
| HK1211577A1 (en) | 2012-08-09 | 2016-05-27 | 细胞基因公司 | Processes for the preparation of (s)-3-4- ((4-(morpholinomethyl) benzyl)oxy)-1-oxoisoindolin-2-yl) piperidine-2,6-dione and pharmaceutically acceptable forms thereof |
| US9695145B2 (en) | 2013-01-22 | 2017-07-04 | Celgene Corporation | Processes for the preparation of isotopologues of 3-(4-((4- morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable salts thereof |
| NZ731789A (en) * | 2014-10-30 | 2019-04-26 | Kangpu Biopharmaceuticals Ltd | Isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereof |
| CA3000547C (en) * | 2015-09-29 | 2021-03-23 | Kangpu Biopharmaceuticals, Ltd. | Pharmaceutical composition comprising benzoheterocyclic compound and androgen receptor pathway modulator for prevention or treatment of prostate cancer |
| SI3526202T1 (sl) * | 2016-10-11 | 2025-04-30 | Arvinas Operations, Inc. | Spojine in postopki za ciljno razgradnjo androgenskih receptorjev |
| JP7062010B2 (ja) * | 2017-01-27 | 2022-05-02 | セルジーン コーポレイション | 3-(1-オキソ-4-((4-((3-オキソモルホリノ)メチル)ベンジル)オキシ)イソインドリン-2-イル)ピペリジン-2,6-ジオン及びそのアイソトポログ |
| JP7258009B2 (ja) * | 2017-07-10 | 2023-04-14 | セルジーン コーポレイション | 抗増殖化合物及びその使用方法 |
| US10513515B2 (en) | 2017-08-25 | 2019-12-24 | Biotheryx, Inc. | Ether compounds and uses thereof |
| SG11202003415XA (en) | 2017-10-18 | 2020-05-28 | Novartis Ag | Compositions and methods for selective protein degradation |
| CN107739389B (zh) | 2017-11-03 | 2020-03-31 | 华东师范大学 | 3位取代的(1-氧代异吲哚啉-2-基)哌啶-2,6-二酮类化合物及其合成方法 |
| IL278854B2 (en) * | 2018-05-23 | 2026-01-01 | Celgene Corp | Multiple myeloma treatment and biomarker use for 4-(4-(4-(((2-(6,2-dioxopyridin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl-3-fluorobenzonitrile |
| WO2020023782A1 (en) * | 2018-07-27 | 2020-01-30 | Biotheryx, Inc. | Bifunctional compounds as cdk modulators |
| KR102947433B1 (ko) | 2019-04-12 | 2026-04-06 | 씨4 테라퓨틱스, 인코포레이티드 | 이카로스 및 아이올로스의 트리시클릭 분해제 |
-
2020
- 2020-07-06 CN CN202010633550.2A patent/CN113896711A/zh active Pending
-
2021
- 2021-06-28 US US18/014,623 patent/US20230271933A1/en active Pending
- 2021-06-28 KR KR1020237004029A patent/KR20230037035A/ko active Pending
- 2021-06-28 JP JP2023500425A patent/JP7712703B2/ja active Active
- 2021-06-28 CN CN202180048474.1A patent/CN115776983A/zh active Pending
- 2021-06-28 WO PCT/CN2021/102873 patent/WO2022007659A1/zh not_active Ceased
- 2021-06-28 MX MX2023000382A patent/MX2023000382A/es unknown
- 2021-06-28 CA CA3189041A patent/CA3189041A1/en active Pending
- 2021-06-28 AU AU2021303635A patent/AU2021303635A1/en active Pending
- 2021-06-28 EP EP21838438.6A patent/EP4177247A4/en active Pending